PharmaLedger Association

📣 We are proud to announce our strategic partnership with NoHarm.ai. 🚀 Earlier this year, we signed a Memorandum of Understanding to connect AstraLabel - ePI by PharmaLedger™'s digital labelling infrastructure with NoHarm.ai's clinical decision-support tools live in the Brazilian healthcare system. This collaboration will bring authoritative medication information (ePI) to pharmacists, nurses, and physicians across more than 200 public and charitable hospitals and clinics in Brazil, free of charge and delivered through the existing NoHarm.ai applications. The bridge of trusted governance and impact between the two non-profit organizations will enable AstraLabel's benefits and safety features to reach the single largest public health system in the world, serving more than 200 million people over the course of this partnership. 🤝 We celebrate this milestone for AstraLabel - ePI by PharmaLedger and NoHarm.ai. A heartfelt thank you to Henrique Dias. We could not have asked for a better partner to demonstrate the potential of non-profit collaboration for open digital infrastructure and clinical AI working together. Read the full announcement. #PatientSafety #DigitalHealth #AstraLabel #NoHarm #Brazil #pharmaledger #nonprofit #regulatorynews #PatientSafety #partners4health

📦 Pharma supply chains are complex. Visibility shouldn't be. While AstraLabel - ePI by PharmaLedger continues to scale digital labelling delivery, we are pleased to showcase another important module of our Product Trust Platform: AstraTrace - a solution developed in a collaboration with distributors and regulators and currently live in Canada tracking vaccines and making sure patients have access when and where they need it. 📌At #Logipharma2026 in Vienna this week — Booth 113 — and we'd love to show you what AstraTrace makes possible. ✅ FMD compliant, EMVS ready! ✅ End-to-end network observability ✅ Alerts before disruptions become crises ✅ From plant to patient — full supply chain coverage Our Executive Director Stefan Schwarzfischer, Dr.-Eng. is also moderating today's panel on Control Towers & E2E visibility (02:40 PM, Hall G1) — catch the session, then come meet the technology behind the conversation. Come find us at Booth 113. ☕ if you are a pharma, come talk to us! if you are a distributor, come talk to us! if you are a cold chain SME, come talk to us! if you are a track and trace SME, come talk to us! PharmaLedger is pre-competition healthcare digital transformation. Dont miss this opportunity! #Logipharma #AstraTrace #AstraLabel #PharmaLedger #epi #SupplyChainVisibility #DigitalPharma #ControlTower #SupplyEcosystem #emvs #fmd Clarisse Dias da Mota James Gannon

🚀We're heading to #Rotterdam! PharmaLedger Association and AstraLabel™ will be at #DIAEurope 2026 — 24–26 March at Rotterdam Ahoy Convention Centre. This year's theme? Collaborating for Healthcare Innovation — and it couldn't be more aligned with what we do every day.🎯 Come find us and let's talk digital labelling, ePI, supply chain transparency, and what the future of pharma looks like. Register: https://lnkd.in/eh8VAPFY #PharmaLedger #AstraLabel #ePI #DigitalHealth #LifeSciences #Pharma #digitallabeling #DIA #RegulatoryAffairs

Global healthcare innovation needs more than technology. It needs trusted frameworks, interoperability, and public–private collaboration - which is where PharmaLedger comes in. That is why we are excited to be part of this global conversation at WHX Dubai 2026. Dubai represents what the future of healthcare innovation looks like: ambitious, global, and governed. A place where technology, regulation, and scale converge. Our Executive Director Stefan Schwarzfischer, Dr.-Eng. will be leading a panel with leaders from GSK, Merck Group and Johnson & Johnson and PharmaLedger will be waiting for you at Booth SP1.C106 for the live demo of our solutions AtraLabel™ & AstraTrace™. More details to come! #TrustedInnovation #PharmaLedger #DigitalHealth #Governance #WHXDubai #GSK #MerckGroup #JohnsonandJohnson

We’re excited to announce that PharmaLedger will be in Dubai for WHX Dubai, from 9–12 February, bringing the conversation on digital trust, traceability, and patient-centric information to the exhibition floor. At our booth, visitors can experience live demos of AstraLabel™ and AstraTrace™, showcasing how digital labeling and end-to-end product observabilty are transforming the pharmaceutical supply chain. We’re also proud to host a high-level panel discussion led by our Executive Director, Stefan Schwarzfischer, Dr.-Eng. bringing together industry leaders to explore digital identification, traceability, and regulatory innovation in healthcare. Panelists include: Fadilla Lakkis - Regulatory Affairs, Intelligence & Communication Manager – Gulf & Near East, GSK and Vice Chair, EFPIA-MERN Dr. Thomas Endress - Executive Director & Head of M-Trust, EMD Digital, Merck Group Shekhar N. - Director, Digital Identification & Traceability, Technical Operations & Risk – Johnson & Johnson Together, the panel will share real-world insights on digital labeling, trust frameworks, and interoperable pharmaceutical supply chains. More details on the panel date/time to come! Meet us at Booth SP1.C106 to connect with our team, experience the live demos of AstraLabel™ and AstraTrace™, and join the discussion shaping the future of digital healthcare. #PharmaLedger #WHXDubai #DigitalHealth #SupplyChain #Traceability #DigitalLabeling #HealthcareInnovation #RegulatoryAffairs #AstraLabel #AstraTrace

Digital shift is accelerating in product information and Pharma needs a scalable plan for ePI & XML Conversions. That is where AstraLabel™ and Glemser comes in. Pharmaceutical companies across Europe are preparing for one of the biggest labeling transformations in years: the move to FHIR-based electronic Product Information (ePI). But with thousands of leaflets to convert and upload in parallel — often in multiple languages — most teams simply don’t have the internal capacity to keep up. That’s why we’re excited to share our new article: “A New Approach to ePI and XML Conversions: Balancing Flexibility, Scale, and Compliance” In it, we explore: → Why outsourcing XML/ePI conversions is becoming essential for early adoption → The new PLA (AstraLabel™) + Glemser joint solution for large-scale eLeaflet conversions → How we support companies struggling with mass uploads and multilingual transformations → How pharma can stay in control while extending conversion capacity → The path from outsourcing > to long-term digital maturity → What EMA’s FHIR mandate means for readiness across the region Whether you're preparing for EMA deadlines or building the foundation for digital labeling globally, this article outlines a practical roadmap to stay compliant, flexible, and future-proof. AstraLabel™: Built for compliance. Ready for scale. From approval to patient in seconds. Read the full article below #DigitalTrasformation #ePI #XMLConversion #PharmaRegulation